Cherry Creek Investment Advisors, Inc. Catalyst Biosciences, Inc. Transaction History

Cherry Creek Investment Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$0.91 - $4.16 $18,200 - $83,200	-20,000 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$3.78 - $5.18 $75,600 - $103,600	20,000 New	20,000 $82,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.